Company profile for Organon

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Organon is a global healthcare company formed through a spinoff from Merck (known as MSD outside of the U.S. and Canada) with a mission to deliver impactful medicines and solutions for a healthier every day. We build upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies and asthma. We bring these important therapies a...
Organon is a global healthcare company formed through a spinoff from Merck (known as MSD outside of the U.S. and Canada) with a mission to deliver impactful medicines and solutions for a healthier every day. We build upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies and asthma. We bring these important therapies around the world, with an international footprint that serves people in more than 140 markets. We believe the diversity of our business provides a sustainable engine of growth so we can continue to invest in and advance

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
30 Hudson Street, Jersey City, NJ 07302
Telephone
Telephone
551-430-6000
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251125341955/en/Organon-To-Present-at-the-Piper-Sandler-37th-Annual-Healthcare-Conference

BUSINESSWIRE
25 Nov 2025

https://www.businesswire.com/news/home/20251117955804/en/Henlius-and-Organon-Announce-US-FDA-Approval-of-POHERDY-pertuzumab-dpzb-the-First-PERJETA-pertuzumab-Biosimilar-in-the-US

BUSINESSWIRE
17 Nov 2025

https://www.fiercepharma.com/pharma/organon-and-henlius-poherdy-first-biosimilar-roches-perjeta-approved-fda

FIERCE PHARMA
14 Nov 2025
Organon Releases Q3 2025 Results
Organon Releases Q3 2025 Results

10 Nov 2025

// BUSINESS WIRE

https://www.businesswire.com/news/home/20251110058374/en/Organon-Reports-Results-for-the-Third-Quarter-Ended-September-30-2025

BUSINESS WIRE
10 Nov 2025

https://www.businesswire.com/news/home/20251108738421/en/New-Data-Show-Early-and-Consistent-Response-to-VTAMA-tapinarof-Cream-1-in-Children-Aged-2-with-Atopic-Dermatitis-Including-Those-With-Associated-Comorbidities

BUSINESSWIRE
08 Nov 2025

https://www.businesswire.com/news/home/20251107954738/en/Organon-Announces-Agreement-to-Divest-its-JADA-System-for-Up-to-%24465-Million-to-Laborie

BUSINESSWIRE
07 Nov 2025

ABOUT THIS PAGE

Contact Organon and get a quotation

Organon is a supplier offers 3 products (APIs, Excipients or Intermediates).

Find a price of Androsterone bulk offered by Organon

Find a price of Ethylestrenol bulk offered by Organon

Find a price of Progesterone bulk offered by Organon

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty